Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
-
David Ray
Professor of Endocrinology, Head of OCDEM, and Co-Director Sir Jules Thorn Sleep and Circadian Neuroscience Institute
Latest publications
-
Genetic determinants of monocyte splicing are enriched for disease susceptibility loci including for COVID-19
Preprint
Fairfax B. et al, (2024)
-
Author Correction: Every islet matters: improving the impact of human islet research
Journal article
Gloyn AL. et al, (2024), Nature Metabolism
-
Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.
Journal article
Thorens B. and Hodson DJ., (2024), Diabetes, 73, 1027 - 1031
-
Author Correction: Self-supervised learning of accelerometer data provides new insights for sleep and its association with mortality.
Journal article
Yuan H. et al, (2024), NPJ Digit Med, 7
Latest News
Jeremy Tomlinson awarded Outstanding Chief Investigator in NIHR celebration
23 July 2024
Congratulations to Professor Jeremy Tomlinson on winning an award for ‘Outstanding Chief Investigator’ from the National Institute of Health and Care Research’s (NIHR) Thames Valley and South Midlands Clinical Research Network (LCRN).
Senior Fellowship awarded to Costas Christodoulides
4 July 2024
Congratulations to Costas Christodoulides, who has been awarded a Senior Clinical Research Fellowship with the British Heart Foundation.
Professor Rajesh Thakker receives OBE in King’s Birthday Honours
17 June 2024
Congratulations to RDM’s Professor Rajesh Vasantlal Thakker FRS, May Professor of Medicine and lately President, Society for Endocrinology, who has been appointed Officer of the Order of the British Empire (OBE) in the King’s Birthday Honours 2024.
The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment
16 April 2024
The first participant has completed initial study activities and is now randomised to one of the trial’s arms.
OCDEM Vacancies
Events
View previous and upcoming events in OCDEM.